Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1786454

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1786454

DNA Synthesizer

PUBLISHED:
PAGES: 221 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global DNA Synthesizer Market to Reach US$787.8 Million by 2030

The global market for DNA Synthesizer estimated at US$322.5 Million in the year 2024, is expected to reach US$787.8 Million by 2030, growing at a CAGR of 16.1% over the analysis period 2024-2030. Benchtop DNA Synthesizers, one of the segments analyzed in the report, is expected to record a 17.9% CAGR and reach US$549.8 Million by the end of the analysis period. Growth in the Large-scale DNA Synthesizers segment is estimated at 12.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$84.8 Million While China is Forecast to Grow at 15.0% CAGR

The DNA Synthesizer market in the U.S. is estimated at US$84.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$121.1 Million by the year 2030 trailing a CAGR of 15.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.0% and 13.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.6% CAGR.

Global DNA Synthesizer Market - Key Trends & Drivers Summarized

Is Synthetic DNA the Fuel Behind the Next Wave of Biotech Innovation?

The rising demand for synthetic DNA is driving a paradigm shift across the biotechnology landscape, with DNA synthesizers positioned at the heart of this transformation. DNA synthesizers, which enable the automated assembly of custom DNA sequences, have become indispensable tools for research, diagnostics, therapeutics, and industrial biotechnology. As synthetic biology gains momentum, scientists are using synthesized DNA to design gene circuits, create novel organisms, and build entire genomes from scratch. The ability to rapidly produce oligonucleotides and gene fragments with high accuracy is accelerating research in CRISPR gene editing, mRNA therapeutics, vaccine development, and metabolic engineering. COVID-19, for example, underscored the value of synthetic DNA in vaccine development, as researchers leveraged synthesizers to quickly prototype viral genes for antigen production. Furthermore, as the cost of DNA synthesis continues to decline, more institutions and biotech startups are integrating synthesizers into their labs to reduce outsourcing costs and enhance project turnaround times. Academic institutions, pharmaceutical companies, and contract research organizations (CROs) are increasingly relying on in-house synthesis capabilities for more flexible and high-throughput workflows. DNA synthesizers are now enabling a shift from single-gene synthesis to large-scale DNA manufacturing for genome assembly, gene libraries, and DNA-based data storage experiments. This growing demand for synthetic DNA in nearly every domain of life sciences positions DNA synthesizers as a strategic technology driving the future of research, innovation, and biomanufacturing.

How Are Technological Advancements Enhancing DNA Synthesis Speed, Accuracy, and Scale?

DNA synthesizer technologies have advanced significantly in recent years, with innovations aimed at improving speed, accuracy, yield, and scalability. Traditional phosphoramidite-based solid-phase synthesis has long been the gold standard for short oligonucleotides, but it faces limitations in sequence length and error accumulation. To overcome these barriers, emerging techniques such as enzymatic DNA synthesis are gaining attention. These methods use engineered polymerases and template-free reactions to synthesize longer and more accurate DNA strands under milder, aqueous conditions-offering potential breakthroughs in both sustainability and efficiency. Additionally, microarray-based synthesis platforms now allow parallel production of thousands of DNA sequences on a single chip, reducing costs and supporting large-scale applications like gene libraries and screening assays. Integration with robotics and automation has made DNA synthesizers more user-friendly, enabling walkaway synthesis with minimal human intervention. Real-time monitoring systems and advanced quality control tools-such as mass spectrometry and capillary electrophoresis-are being incorporated into next-generation synthesizers to ensure product purity and yield. AI and machine learning algorithms are also being utilized to predict synthesis errors and optimize protocols in real time, increasing reproducibility and customization. These innovations are expanding the reach of DNA synthesis beyond standard laboratory use to clinical research, precision medicine, and industrial-scale production. By pushing the boundaries of what can be synthetically engineered, modern DNA synthesizers are playing a crucial role in reshaping the pace and potential of genomic science.

Is the Broadening End-User Base Reshaping Commercial Strategies in the DNA Synthesizer Market?

The DNA synthesizer market is experiencing significant diversification in its end-user base, which is prompting manufacturers to tailor their technologies and services to suit varying levels of expertise, application focus, and throughput needs. Academic institutions and core research labs remain key users, utilizing synthesizers for fundamental genetic and cellular biology research. However, the market is witnessing a sharp rise in adoption among pharmaceutical companies, diagnostics firms, and synthetic biology startups that require high-volume, application-specific DNA synthesis for clinical trials, therapeutic development, and product innovation. Companies working in the fields of agriculture, industrial enzymes, and biofuels are also using DNA synthesizers to optimize genetically modified organisms (GMOs) and microbial production systems. The growing interest in DNA data storage is creating a niche segment of high-capacity synthesizers tailored for encoding digital data into DNA strands. As demand diversifies, commercial strategies are evolving: manufacturers now offer benchtop synthesizers for low-throughput labs, high-capacity platforms for industrial users, and cloud-based synthesis-as-a-service models for institutions seeking access without owning physical equipment. These service models are particularly popular among startups and academic researchers looking for cost-effective access to high-quality DNA without large capital expenditure. Additionally, training programs, software integrations, and on-demand support are becoming integral to commercial offerings, ensuring that users of all levels can effectively operate and maintain synthesizers. By aligning technology with the needs of diverse user groups, companies are strengthening their market position and fostering broader adoption of in-house DNA synthesis capabilities across the life sciences spectrum.

What Are the Key Market Drivers Fueling Demand for DNA Synthesizers Globally?

The growth in the DNA synthesizer market is driven by several interlinked factors rooted in technological innovation, expanding applications, and evolving user demands. One of the primary drivers is the rising adoption of synthetic biology in fields such as therapeutics, agriculture, and bio-manufacturing, where synthetic DNA is foundational to designing biological systems and custom organisms. The need for rapid prototyping in vaccine development, especially mRNA and DNA-based platforms, is also fueling investment in high-throughput DNA synthesis equipment. Additionally, the global expansion of CRISPR and gene editing research is driving the need for precision-engineered guide RNAs and donor templates, further boosting synthesizer usage. Another growth factor is the demand for decentralized, in-house DNA synthesis solutions that reduce dependency on outsourcing and accelerate project timelines-especially important in fast-paced biotech environments. The increasing integration of automated synthesizers into lab workflows, coupled with the development of cost-effective consumables, is making DNA synthesis more accessible to mid-sized labs and startups. Regulatory trends favoring personalized medicine and precision diagnostics are also stimulating the development of synthesizers that can produce DNA for targeted assay development and clinical research. Furthermore, strategic collaborations between synthesizer manufacturers, academic institutions, and pharmaceutical companies are accelerating product innovation and distribution. The advent of next-generation synthesis technologies, such as enzymatic and chip-based systems, is opening new commercial avenues with improved sustainability, accuracy, and scalability. Lastly, the growing focus on biotechnology education and workforce development is creating demand for academic synthesizers and training kits, ensuring long-term market expansion. Together, these diverse yet converging drivers are positioning DNA synthesizers as a cornerstone technology powering the next frontier of genomic science and bioengineering.

SCOPE OF STUDY:

The report analyzes the DNA Synthesizer market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Benchtop DNA Synthesizers, Large-scale DNA Synthesizers); Application (Drug Discovery & Development Application, Genetic Engineering Application, Clinical Diagnostics Application); End-Use (Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use, Clinical Laboratories End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Agilent Technologies, Inc.
  • Applied Biosystems (Thermo Fisher Scientific)
  • ATDBio Ltd.
  • ATG:biosynthetics GmbH
  • ATUM
  • Azenta Life Sciences
  • BaseClear B.V.
  • BioAutomation Corporation
  • Biolegio B.V.
  • Biosearch Technologies (LGC Group)
  • Bioneer Corporation
  • Biotage AB
  • Biosynthesis, Inc.
  • CSBio Company, Inc.
  • DNA Script
  • Eurofins Genomics
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc. (IDT)
  • Kilobaser GmbH
  • LGC Biosearch Technologies

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP30560

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • DNA Synthesizer - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Boom in Synthetic Biology and Genomic Engineering Throws the Spotlight on Automated DNA Synthesis Platforms
    • Rising Demand for Custom Genes and Oligonucleotides Propels Growth in On-Demand DNA Synthesizer Adoption
    • Declining Cost of DNA Synthesis Strengthens Business Case for In-House Synthesizer Integration
    • Advancements in Enzymatic and Chip-Based Synthesis Methods Accelerate Market Transition from Traditional Chemistries
    • Integration of DNA Synthesizers with Lab Automation Systems Drives Efficiency in High-Throughput Workflows
    • Proliferation of CRISPR and Gene Editing Applications Expands Use of Synthesizers in Research and Therapeutics
    • Growing Role of DNA in Data Storage and Nanotechnology Opens New Commercial Avenues for DNA Synthesizer Technologies
    • Academic and Biotech Startups Turn to Benchtop Synthesizers to Reduce Outsourcing and Speed R&D Cycles
    • Rising Demand for Synthetic Gene Libraries Spurs Need for Scalable, Multiplexed Synthesis Platforms
    • Use of AI for Sequence Optimization Enhances Accuracy, Customization, and Yield of Synthesized DNA
    • Growth in Vaccine Development and mRNA Therapeutics Generates Demand for Rapid and Flexible DNA Synthesis
    • Expansion of Biofoundries and Distributed Manufacturing Models Strengthens Demand for Modular Synthesizer Units
    • Global Investment in Synthetic Genomics Research Sustains Long-Term Growth Opportunities for DNA Synthesizer Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World DNA Synthesizer Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for DNA Synthesizer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for DNA Synthesizer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for DNA Synthesizer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Benchtop DNA Synthesizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Benchtop DNA Synthesizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Benchtop DNA Synthesizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Large-scale DNA Synthesizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Large-scale DNA Synthesizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Large-scale DNA Synthesizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Drug Discovery & Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Genetic Engineering Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Genetic Engineering Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Genetic Engineering Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Clinical Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Clinical Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Clinical Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Clinical Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for DNA Synthesizer by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for DNA Synthesizer by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of World 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of World 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!